HOME >> MEDICINE >> NEWS
Subanalysis finds patient-controlled, transdermal pain management system may be comparable

Phoenix, Arizona, November 15, 2004 - Researchers have reported that IONSYSTM, a novel patient-controlled, transdermal, analgesic system that delivers fentanyl through the skin, may be comparable to intravenous patient-controlled analgesia (IV PCA) when used after gynecologic surgery. This needle-free system for managing acute pain in the hospital setting is currently under review by the Food and Drug Administration (FDA), and was granted approvable status in June, 2004. These data were presented at the American Society of Regional Anesthesia & Pain Medicine Annual Fall Pain Meeting.

This research is a subanalysis of a broader, head-to-head study published earlier this year in the Journal of the American Medical Association (JAMA). The complete set of data showed that 316 adult patients receiving IONSYSTM following major surgery experienced similar pain relief as that experienced with IV PCA morphine. This subanalysis focuses on the women in the study who had undergone gynecologic surgery. Patients received either IONSYSTM fentanyl HCl 40mcg -- a system that is designed to be the first and only needle-free, patient-controlled, transdermal analgesic to treat acute pain -- or the current standard of therapy, morphine via IV PCA. IONSYSTM currently is under development and not yet commercially available.

Researchers reported no statistically-significant differences between the two methods in patients' overall pain control, the amount of supplemental pain medication required, or the number of patients withdrawing from the study due to inadequate pain relief. Side effects were similar in both groups.

"In 2002, there were more than a million gynecologic surgeries performed in the United States," said Shireen Ahmad, M.D., Assistant Professor, Department of Anesthesiology at Northwestern University. "In this subanalysis, IONSYSTM provided post-operative pain relief to most patients und
'"/>


15-Nov-2004


Page: 1 2 3

Related medicine news :

1. Study finds that coordinating care of chronically ill patients does not increase liability
2. Bullying among sixth graders a daily occurrence, UCLA study finds
3. Study finds factors linked to substance use disorder relapse among health care professionals
4. Study finds majority of women willing to accept cervical cancer vaccine for self and children
5. Boston University team finds link between high cholesterol and better cognitive performance
6. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
7. Study finds direct association between cardiovascular disease and periodontal bacteria
8. Emory Study finds HIV is not an independent risk factor for severe heart disease
9. Study finds indoor allergen levels vary, cockroach allergens cause more asthma symptoms
10. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis
11. Men more likely to get screened for prostate cancer than colon cancer, U-M study finds

Post Your Comments:
(Date:6/19/2013)... block the body,s system for repairing damage to the ... unlikely as it may seem, those compounds are sparking ... driven by a mutation in BRCA, a gene that ... the mutation. The compounds, termed PARP inhibitors, are the ... of Chemical & Engineering News . C&EN is ...
(Date:6/19/2013)... June 19, 2013 North Carolina-based ... organizational changes to advance development of its technologies. ... “To support the advanced development of our product ... to the Company’s management structure and engaged industry ... Company announced that Michael Galiger will serve as ...
(Date:6/19/2013)... Louisiana State University have developed a method for identifying ... on understanding the genetic interaction between single nucleotide polymorphisms ... cancer,s aggressiveness to avoid unnecessary radical treatment. , ... PLOS ONE in April. , According to the ... cancers and 9 percent of cancer deaths. It is ...
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s indoor ... Saver kit at an exceptional price. The 5-2-1 Compressor Saver ... conditioning unit during start up, saving wear and tear on ... burn out. , The 5-2-1 Compressor Saver works ... less power to start and drastically reduces the rush of ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Alternatives, a ... some patients to quit using drugs while allowing them ... Jaffe, the founders of Alternatives, believe that abstinence-only approaches ... they enter treatment and that this approach hurts instead ... people in the United States need treatment for addiction ...
Breaking Medicine News(10 mins):Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3
(Date:6/19/2013)... WHITE PLAINS, N.Y. , June 19, 2013 /PRNewswire/ ... is supporting more than 300 research projects with one ... patients. And in 2013, "Team In Training" (TNT), a ... largest endurance sports training program, is marking its landmark ... LLS invest more than $875 million in research to ...
(Date:6/19/2013)... June 19, 2013  Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... the number one overall pharmacy equipment vendor in ... KLAS, a leading independent healthcare research firm, compared ... in its annual rankings. Omnicell also received the ...
(Date:6/19/2013)... , 19. Juni 2013 /PRNewswire/ ... dass mit der Entwicklung von SCS ... Schritt in der Beschichtung mit Parylene ... Vorteile von biokompatiblem Parylene mit antimikrobiellen ... Beseitigung schädlicher Mikroorganismen auf beschichteten medizinischen ...
Breaking Medicine Technology:Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
Cached News: